{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:34:45Z","timestamp":1788564885006,"version":"build-2803163510"},"reference-count":44,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["AIDS Patient Care and STDs"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:p>\n                    Poor compliance with medications is a growing concern in geriatric care and is increasingly more relevant among people living with HIV (PLWH) as they age. Our goal was to understand geriatric conditions associated with antiretroviral therapy (ART) nonadherence in a Medicare population of older PLWH. We analyzed Medicare data from PLWH aged 50 years or older who were continuously enrolled in fee-for-service Medicare from January 1, 2014 to June 30, 2015. Prevalent geriatric conditions (dementia, depression, falls, hip fracture, sensory deficits, osteoporosis, orthostatic hypotension, urinary incontinence, frailty) were identified in January 1, 2014\u2013December 31, 2014. ART nonadherence was defined as &lt;80% proportion of days covered (PDC) by at least two ART medications in January 1, 2015\u2013June 30, 2015. We examined geriatric condition association with nonadherence using lowest Akaike Information Criterion multi-variate logistic models, controlling for age, sex, race, census region, substance use, Medicaid eligibility, and polypharmacy. Of 8778 PLWH, 23% (\n                    <jats:italic toggle=\"yes\">n<\/jats:italic>\n                    \u2009=\u20092042) had &lt;80% PDC. The average age was 60 years (standard deviation \u00b18), and &gt;70% were males. In adjusted models, age was not associated with nonadherence, frailty status was the only geriatric condition associated with nonadherence [robust: reference, prefrail odds ratio (OR): 0.97, confidence interval (95% CI) 0.86\u20131.10, frail OR: 1.34 95% CI 1.11\u20131.61], and odds of nonadherence were lower for polypharmacy [OR: 0.48 (0.43\u20130.54)]. Our findings suggest that patient-centered care plans aimed at improving ART adherence among older PLWH would benefit from long-term surveillance; a deeper understanding of the role of frailty and polypharmacy, even at chronologically younger ages in PLWH.\n                  <\/jats:p>","DOI":"10.1089\/apc.2022.0040","type":"journal-article","created":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T15:25:06Z","timestamp":1654874706000},"page":"226-235","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":14,"title":["Geriatric Conditions Associated with Nonadherence to Antiretroviral Therapy Among Older People with HIV: The Importance of Frailty"],"prefix":"10.1177","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6739-2019","authenticated-orcid":false,"given":"Brianne","family":"Olivieri-Mui","sequence":"first","affiliation":[{"name":"The Roux Inst and Department of Health Sciences, Northeastern University, Boston, Massachusetts, USA."},{"name":"The Marcus Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira","family":"Wilson","sequence":"additional","affiliation":[{"name":"Department of Health Services, Policy and Practice, Brown University School of Public Health, Providence, Rhode Island, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Shi","sequence":"additional","affiliation":[{"name":"The Marcus Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monty","family":"Montano","sequence":"additional","affiliation":[{"name":"Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen P.","family":"McCarthy","sequence":"additional","affiliation":[{"name":"The Marcus Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1598-4693","authenticated-orcid":false,"given":"Gahee","family":"Oh","sequence":"additional","affiliation":[{"name":"The Marcus Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Hyun","family":"Kim","sequence":"additional","affiliation":[{"name":"The Marcus Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2022,6,9]]},"reference":[{"key":"e_1_3_4_2_2","unstructured":"U.S. Department of Health and Human Services. Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents: Recommendations from the Centers for Disease Control and Prevention. Atlanta GA: National Institutes of Health and the HIV Medicine Association of the Infectious Disease Society of America; 2013."},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-013-0107-7"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200418001-00004"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1037\/0278-6133.26.1.40"},{"key":"e_1_3_4_6_2","unstructured":"Centers for Disease Control and Prevention. HIV and Older Americans. Available at: https:\/\/www.cdc.gov\/hiv\/group\/age\/olderamericans\/index.html (Last accessed June30 2021)."},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2018-000823"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001374"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir627"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-016-1325-x"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2019.1612020"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000002460"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-013-0093-9"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25188"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s41999-018-0144-1"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2008.02150.x"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000556"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2018.0190"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2016.1219445"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2007.01156.x"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2020.0051"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-010-0041-9"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.16436"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2318-8-24"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu258"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.12695"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-013-2449-6"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001685"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2016.10.015"},{"key":"e_1_3_4_30_2","first-page":"e27","article-title":"Is polypharmacy associated with frailty in older people? Results from the ESTHER Cohort Study","volume":"65","author":"Saum KU","year":"2017","unstructured":"Saum KU, , Sch\u00f6ttker B, , Meid AD, et al. Is polypharmacy associated with frailty in older people? Results from the ESTHER Cohort Study. J Am Geriatr Soc (JAGS), 2017; 65:e27\u2013e32.","journal-title":"J Am Geriatr Soc (JAGS)"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0543"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1331\/JAPhA.2014.13165"},{"key":"e_1_3_4_33_2","unstructured":"Department of Health and Human Services. Management of the Treatment-Experienced Patient: Discontinuation or Interruption of Antiretroviral therapy. Available at: https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/adult-and-adolescent-arv\/discontinuation-or-interruption-antiretroviral-therapy?view=full (Last accessed June5 2021)."},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.32481\/djph.2019.05.012"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-014-0142-1"},{"issue":"1","key":"e_1_3_4_36_2","first-page":"S1","article-title":"HIV and aging: State of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group","volume":"60","author":"High KP","year":"2012","unstructured":"High KP, , Brennan-Ing M, , Clifford DB, et al. HIV and aging: State of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr (1999), 2012; 60 Suppl 1(Supplement 1):S1\u2013S18.","journal-title":"J Acquir Immune Defic Syndr (1999)"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.16955"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2012.301161"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afs100"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.13445"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2015.0199"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2012.752566"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1080\/07317115.2018.1456500"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.15950"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1007\/s41999-018-0143-2"}],"container-title":["AIDS Patient Care and STDs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/apc.2022.0040","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/apc.2022.0040","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/apc.2022.0040","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:04:31Z","timestamp":1777399471000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/apc.2022.0040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["10.1089\/apc.2022.0040"],"URL":"https:\/\/doi.org\/10.1089\/apc.2022.0040","relation":{},"ISSN":["1087-2914","1557-7449"],"issn-type":[{"value":"1087-2914","type":"print"},{"value":"1557-7449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6]]}}}